Biomedical Information Management and Analytic Support Services

The National Cancer Institute established this Master IDIQ on September 16, 2020, to procure biomedical information management and analytic support services for cancer epidemiology and genetics research programs, but ordering closed on September 15, 2025, and the vehicle is no longer active for new task orders.

The vehicle supported data modeling, acquisition, management, and analytics for domestic and international epidemiological studies spanning prospective cohort studies, case-control studies, family studies, and randomized clinical trials. Work included statistical programming, bioinformatics analysis, cloud-based data platform development, and interactive web application development for cancer research data. The combined $148 million shared ceiling has generated 10 task orders worth $68.1 million in combined potential value, with $45.4 million obligated as of the most recent award in March 2025.

Information Management Services, Inc. captured dominant market share, holding 4 of 10 orders with $63.3 million combined potential value—approximately 93 percent of the vehicle's total. Deloitte Consulting LLP, Research Triangle Institute, and Booz Allen Hamilton Inc. each received 2 orders; the remaining $4.8 million in potential value spread across these three firms. All task orders carried unrestricted, competitive designations with no set-aside.

The National Cancer Institute funded 9 of 10 orders totaling $67.9 million potential value; the National Human Genome Research Institute issued one order for $110 thousand. Ordering momentum declined sharply after 2022, with only 1 order placed in 2023 and 1 in 2025, compared to 3 orders in 2020 and 2022 combined.

Task orders ranged from small specialized efforts under $110 thousand to the most recent delivery order to Information Management Services, Inc., valued at $27.3 million ceiling through January 2030, with $7.3 million obligated for the base period. Pricing was predominantly cost-plus-fixed-fee; two orders used firm fixed price. Performance periods typically extended two to five years. The vehicle supported NIH cancer research infrastructure rather than commercial or broader federal analytics demand, and the closing of the ordering period signals transition to a successor vehicle or internal NCI capability.

Provide biomedical information management and analytic support services in support of the ongoing epidemiology and genetic research programs, conducted in the Branches and Laboratories in Division of Cancer Epidemiology and Genetics (DCEG), which include domestic and international studies with diverse study designs in epidemiology and genetics research including prospective cohort studies, case-control studies, family studies, and randomized clinical trials. Tasks include Data Modeling, Acquisition and Management, Data Analytics, Statistical and Bioinformatic Analysis, and Tool Development.